Moberg Pharma AB (publ) (STO: MOB)

Moberg Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Jun 30, 2020
Market Capitalization	853	425	228	237	143	272
Market Cap Growth	165.33%	86.42%	-3.61%	65.26%	-47.37%	-82.90%
Enterprise Value	547	327	87	130	127	229
Last Close Price	18.26	15.20	23.20	51.85	56.32	113.65
PE Ratio	-	-	-	30.50	18.36	10.72
Forward PE	-	69.34	69.34	69.34	69.34	69.34
PS Ratio	68.94	-	1101.38	-	4.25	5.39
PB Ratio	0.92	0.70	0.43	0.54	0.36	0.83
P/TBV Ratio	1.37	0.70	0.43	0.54	0.37	0.85
P/FCF Ratio	-	-	-	-	-	68.81
P/OCF Ratio	-	-	-	-	-	68.81
PEG Ratio	115.56	115.56	115.56	115.56	115.56	115.56
EV/Sales Ratio	62.31	-	421.77	-	3.76	4.54
EV/EBITDA Ratio	-	-	-	-	12.82	7.92
EV/EBIT Ratio	-	-	-	-	12.88	8.67
EV/FCF Ratio	-	-	-	-	-	58.02
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.02	0.04
Debt / EBITDA Ratio	-	-	-	-	0.60	0.46
Debt / FCF Ratio	-	-	-	-	-	3.40
Asset Turnover	0.01	-	0.00	-	-	0.06
Quick Ratio	22.03	2.99	4.74	6.68	0.27	1.44
Current Ratio	22.52	3.38	4.77	6.74	2.08	1.44
Return on Equity (ROE)	-2.36%	-3.69%	-3.25%	-3.91%	-	2.76%
Return on Assets (ROA)	-2.00%	-2.91%	-2.53%	-2.65%	-	2.10%
Return on Capital (ROIC)	-2.04%	-3.02%	-2.62%	-2.93%	-	2.21%
Earnings Yield	-3.02%	-4.96%	-6.89%	3.17%	4.10%	7.36%
FCF Yield	-5.90%	-7.81%	-7.39%	-6.47%	-7.27%	1.45%
Buyback Yield / Dilution	-191.30%	-109.19%	-76.29%	-127.45%	-0.34%	-5.79%
Total Shareholder Return	-191.30%	-109.19%	-76.29%	-127.45%	-0.34%	-5.79%

Source: S&P Capital IQ. Standard template. Financial Sources.